Primary Record
beta-Antiarin
Note: Only for scientific research or as raw materials for production; they are not drugs and must not be ingested.
- In stock
- 8,539 g
- Purity
- 98.7 %
- CAS
- 639-13-4
Compound Identifiers & Properties
- CAS
- 639-13-4
- PubChem CID
- 6325617
- SMILES
- C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4C[C@H]([C@@]5([C@H](CC[C@@]5([C@@H]4CC[C@@]3(C2)O)O)C6=CC(=O)OC6)C)O)C=O)O)O)O
- Canonical SMILES
- C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4C[C@@H](O)[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O
Names & Synonyms
- beta-Antiarin
- Hadacidin
- |A-antiarin
- UNII-JI0QAN6VB0
- Antiarigenin + L-rhamnose
- JI0QAN6VB0
- .BETA.-ANTIARIN
- RefChem:119205
- AC1O3DN2
- Antiarigenin + L-rhamnose [German]
- CHEMBL1075787
- CID6325617
- 639-13-4
- C29-H42-O11
- J17.016J
- (3S,5S,8R,9S,10S,12R,13S,14S,17R)-5,12,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
- 5-beta-Card-20(22)-enolide, 19-oxo-3-beta-((L-rhamnopyranosyl)oxy)-5,12-beta,14-trihydroxy-
- CARD-20(22)-ENOLIDE, 3-((6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)OXY)-5,12,14-TRIHYDROXY-19-OXO-, (3.BETA.,5.BETA.,12.BETA.)-
- 5,12|A,14-Trihydroxy-19-oxo-3|A-|A-L-rhamnopyranosyloxy-5|A,14|A-card-20(22)-enolid
- (1R,3aS,3bR,5aS,7S,9aS,9bS,11R,11aS)-3a,5a,11-trihydroxy-11a-methyl-1-(5-oxo-2,5-dihydrofuran-3-yl)-7-{[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-hexadecahydro-1H-cyclopenta[a]phenanthrene-9a-carbaldehyde
- (3S,5S,8R,9S,10S,12R,13S,14S,17R)-5,12,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthrene-10-carbaldehyde
- 3beta-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-5,12beta,14-trihydroxy-19-oxo-5beta-card-20(22)-enolide
- CARD-20(22)-ENOLIDE, 3-((6-DEOXY-ALPHA-L-MANNOPYRANOSYL)OXY)-5,12,14-TRIHYDROXY-19-OXO-, (3BETA,5BETA,12BETA)-